Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000891293-08-000002
Filing Date
2008-03-20
Accepted
2008-03-20 17:09:01
Documents
1
Period of Report
2008-03-18

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 2988
  Complete submission text file 0000891293-08-000002.txt   4926
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Issuer) CIK: 0000891293 (see all company filings)

EIN.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SPACELABS MEDICAL INC 15220 NE 40TH ST REDMOND WA 98053
Business Address GROUP HEALTH COOPERATIVE OF PUGET SOUND 521 WALL ST SEATTLE WA 98121
NUDELMAN PHILLIP M PHD (Reporting) CIK: 0001041084 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-12465 | Film No.: 08703222